Core Insights - Exelixis (EXEL) is expected to report quarterly earnings of 562.88 million, a 17.4% increase from the previous year [1]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate for the quarter has been revised upward by 3.3%, indicating analysts' reassessment of their initial forecasts [2]. - Changes in earnings estimates are crucial for predicting investor reactions to the stock, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Revenues- Net product' to be 501.25 million, indicating a 17.2% year-over-year change [5]. - 'Revenues- License' is expected to be 1.94 million, which indicates a significant decline of 61.9% from the year-ago quarter [6]. Stock Performance - Exelixis shares have decreased by 2.8% over the past month, contrasting with the Zacks S&P 500 composite's increase of 2.1% [6]. - With a Zacks Rank 2 (Buy), Exelixis is anticipated to outperform the overall market in the near term [6].
Curious about Exelixis (EXEL) Q4 Performance? Explore Wall Street Estimates for Key Metrics